Esmeralda Delgado

942 total citations
44 papers, 695 citations indexed

About

Esmeralda Delgado is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Esmeralda Delgado has authored 44 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Esmeralda Delgado's work include Retinal Diseases and Treatments (9 papers), Ocular Surface and Contact Lens (8 papers) and Retinal Development and Disorders (7 papers). Esmeralda Delgado is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Ocular Surface and Contact Lens (8 papers) and Retinal Development and Disorders (7 papers). Esmeralda Delgado collaborates with scholars based in Portugal, Germany and Paraguay. Esmeralda Delgado's co-authors include Berta São Bráz, R Cohen, Martin H. Kalser, Donald G. Ahearn, Frank J. Roth, Lídia Gonçalves, Jürgen Knobloch, Isabel Pereira da Fonseca, Ana Mafalda Lourenço and Ralf Bialek and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Esmeralda Delgado

43 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esmeralda Delgado Portugal 14 181 148 137 134 105 44 695
C. Chaumeil France 20 105 0.6× 314 2.1× 541 3.9× 48 0.4× 17 0.2× 69 967
B. R. Jones United Kingdom 15 127 0.7× 136 0.9× 183 1.3× 30 0.2× 28 0.3× 27 702
P. Goldschmidt France 21 78 0.4× 250 1.7× 472 3.4× 47 0.4× 20 0.2× 80 1.1k
Gita Satpathy India 22 219 1.2× 485 3.3× 858 6.3× 18 0.1× 36 0.3× 91 1.4k
Mohammad Soleimani Iran 17 90 0.5× 401 2.7× 658 4.8× 18 0.1× 37 0.4× 154 1.3k
Praveen Kumar Balne India 18 103 0.6× 152 1.0× 396 2.9× 77 0.6× 3 0.0× 54 803
Zemira Samra Israel 15 103 0.6× 123 0.8× 31 0.2× 22 0.2× 8 0.1× 34 529
Avinash Pathengay India 24 159 0.9× 118 0.8× 1.6k 11.6× 60 0.4× 9 0.1× 127 1.8k
E Eylan Israel 13 189 1.0× 83 0.6× 58 0.4× 32 0.2× 7 0.1× 95 599
Sandra Scheiblhofer Austria 28 146 0.8× 117 0.8× 7 0.1× 54 0.4× 123 1.2× 72 1.9k

Countries citing papers authored by Esmeralda Delgado

Since Specialization
Citations

This map shows the geographic impact of Esmeralda Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmeralda Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmeralda Delgado more than expected).

Fields of papers citing papers by Esmeralda Delgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmeralda Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmeralda Delgado. The network helps show where Esmeralda Delgado may publish in the future.

Co-authorship network of co-authors of Esmeralda Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of Esmeralda Delgado. A scholar is included among the top collaborators of Esmeralda Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esmeralda Delgado. Esmeralda Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delgado, Esmeralda, et al.. (2025). Topical Ocular Drug Delivery: The Impact of Permeation Enhancers. Pharmaceutics. 17(4). 447–447. 5 indexed citations
2.
Silva, Beatriz, Lídia Gonçalves, Berta São Bráz, & Esmeralda Delgado. (2023). Topical Administration of a Nanoformulation of Chitosan-Hyaluronic Acid-Epoetin Beta in a Rat Model of Glaucoma. Pharmaceuticals. 16(2). 164–164. 7 indexed citations
3.
Gonçalves, Lídia, et al.. (2023). Topical ocular delivery of nanoparticles with epoetin beta in Wistar Hannover rats. Scientific Reports. 13(1). 1559–1559. 11 indexed citations
4.
Delgado, Esmeralda, et al.. (2021). Clinical signs of brachycephalic ocular syndrome in 93 dogs. Irish Veterinary Journal. 74(1). 3–3. 42 indexed citations
5.
Bráz, Berta São, et al.. (2017). Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera. Drug Delivery and Translational Research. 7(5). 625–631. 21 indexed citations
6.
Bráz, Berta São, et al.. (2016). Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats. Ophthalmic Research. 56(2). 104–110. 10 indexed citations
7.
Bráz, Berta São, et al.. (2013). Alternative route for erythropoietin ocular administration. Graefe s Archive for Clinical and Experimental Ophthalmology. 251(8). 2051–2056. 12 indexed citations
8.
Delgado, Esmeralda. (2012). Dacryops of the lacrimal gland in a dog. Veterinary Ophthalmology. 16(2). 153–158. 9 indexed citations
9.
Lourenço, Ana Mafalda, et al.. (2011). Allergic conjunctivitis and conjunctival provocation tests in atopic dogs. Veterinary Ophthalmology. 14(4). 248–256. 18 indexed citations
10.
Maia, Carla, Esmeralda Delgado, Maria C. Peleteiro, & Lenea Campino. (2011). Ocular clinical manifestations and histopathological features in experimental canine leishmaniasis.. 18. 1 indexed citations
11.
Delgado, Esmeralda, et al.. (2010). CASE REPORT: Amelanotic uveal cyst in a Yorkshire terrier dog. Veterinary Ophthalmology. 13(5). 343–347. 3 indexed citations
12.
Delgado, Esmeralda, et al.. (2009). Endothelin‐1 effects on spontaneous oscillations in choroidal arterioles. Acta Ophthalmologica. 88(7). 742–747. 9 indexed citations
13.
Delgado, Esmeralda, et al.. (2009). <i>L</i>-Arginine and <i>L</i>-Nitroarginine Methylester Effects on Vasomotion in Isolated Rabbit Eyes. Ophthalmic Research. 43(3). 113–121. 4 indexed citations
14.
Delgado, Esmeralda, et al.. (2008). Intrinsic vasomotricity and adrenergic effects in a model of isolated rabbit eye. Acta Ophthalmologica. 87(4). 443–449. 16 indexed citations
15.
Marques‐Neves, Carlos, et al.. (2004). Intraocular Pressure Variability in the Anesthetized Rat: A Spectral Analysis. European Journal of Ophthalmology. 14(5). 381–386. 6 indexed citations
16.
Delgado, Esmeralda, et al.. (2003). CRYPTOSPORIDIUM SPP. IN RUMINANTS AT THE LISBON ZOO. Journal of Zoo and Wildlife Medicine. 34(4). 352–356. 11 indexed citations
17.
Alves, Margarida, Olga Matos, Isabel Pereira da Fonseca, et al.. (2001). Multilocus Genotyping of Cryptosporidium Isolates from Human HIV‐Infected and Animal Hosts. Journal of Eukaryotic Microbiology. 48(s1). 17S–18S. 31 indexed citations
18.
Delgado, Esmeralda, et al.. (2000). Some aspects of cryptosporidiosis in wild ruminants in the Lisbon Zoo.. 7. 33–38. 1 indexed citations
19.
Maass, Matthias, Esmeralda Delgado, & Jürgen Knobloch. (1992). Isolation of an immunodiagnostic Taenia solium coproantigen.. PubMed. 43(3). 201–2. 10 indexed citations
20.
Knobloch, Jürgen, et al.. (1985). Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel.. PubMed. 36(2). 88–90. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026